|

SIENTIFIC
ADVISORY BOARD

Alice
Bendix Gottlieb MD, PhD
is an internationally
recognized expert and leader in the field of psoriasis
and psoriatic arthritis. In March, 2006, she joined
Tufts-New England Medical Center as its Chair of Dermatology
and Dermatologist-in-Chief of the hospital, and as
the Harvey B. Ansell Professor of Dermatology at Tufts
University School of Medicine.Her research using targeted
immunobiologics as pathogenic probes, provided new
understanding of the pathogenesis of psoriasis and
provided the foundation for biologic drug development
in psoriasis and psoriatic arthritis. She has authored
over 155 peer-reviewed articles that have appeared
in journals such as The Lancet, the New England Journal
of Medicine, Nature: Drug Discovery, Proceedings of
the National Academy of Sciences, Journal of Experimental
Medicine, Archives of Dermatology, the Journal of
the American Academy of Dermatology, and Journal of
Investigative Dermatology.For more information on
her work, visit her laboratory's webpage by
clicking
here.

Dr.
Donald Reitberg PhD
Founder, Vice Chairman
and Chief Scientific Officer Formerly Vice President
of Research and Development for Novartis Consumer
Health. Over 20 years experience in clinical research
and clinical operations for Rx and OTC product development
with Pfizer, Sterling Drug, American Home Products
and SmithKline Beecham. B.A., Hunter College; B.S.,
Pharmacy, University of Utah; PharmD., State University
of New York at Buffalo; Fellowship in Clinical Pharmacokinetics
and Pharmacology at Millard Fillmore Hospital, Buffalo,
NY Registered Pharmacist in NY, NJ and Utah clicking
here.

Dr.
Alexander Skorobogatko MD,
PhD
is
a well-recognized expert in clinical research. He
pioneered expansion of clinical trials in Ukraine.
He has published extensively on clinical research
in neurology, psychiatry, dermatology, rheumatology
and cardiology
areas.
Next>
|
Board
Members:
A
B Gottlieb MD, PhD
D
Reitberg PhD
A
Skorobogatko MD, PhD
|